About HUG; Oncologie
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at HUG; Oncologie
During the past decade, HUG; Oncologie conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 4 clinical trials were completed, i.e. on
average, 133.3% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Efficacy and Safety Study of CC-5013 Monotherapy in Subjects With Myelodysplastic Syndromes
2003-06-01
2007-02-01
Completed
215
A Study of Bevacizumab (Avastin®) in Combination With Temozolomide and Radiotherapy in Participants With Newly Diagnosed Glioblastoma
2009-06-29
2015-09-09
Completed
921
Study to Evaluate the Safety and Efficacy of Pomalidomide Monotherapy in Subjects With Refractory or Relapsed Refractory Multiple Myeloma
2011-03-01
2014-07-31
Completed
74
A Study of Onartuzumab (MetMAb) in Combination With Bevacizumab Compared to Bevacizumab Alone or Onartuzumab Monotherapy in Participants With Recurrent Glioblastoma
2012-06-29
2016-01-21
Completed
135
A Study of Atezolizumab Compared With Docetaxel in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Failed Platinum-Containing Therapy
2014-03-11
2019-01-09
Completed
1,225
A Study of Atezolizumab Compared With Chemotherapy in Participants With Locally Advanced or Metastatic Urothelial Bladder Cancer [IMvigor211]
2015-01-13
2018-11-08
Completed
931
A Study of Atezolizumab in Locally Advanced or Metastatic Urothelial or Non-Urothelial Carcinoma of the Urinary Tract
2016-11-30
2022-12-12
Completed
1,005
Basket Study to Evaluate the Therapeutic Activity of Simlukafusp Alfa as a Combination Therapy in Participants With Advanced and/or Metastatic Solid Tumors
2018-02-19
2021-12-30
Terminated
256
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at HUG; Oncologie
According to Clinical.Site data, the most researched conditions in "HUG; Oncologie" are
"Glioblastoma" (2 trials), "Advanced/Metastatic Head and Neck, Oesophageal and Cervical Cancers" (1 trials), "Bladder Cancer" (1 trials), "Multiple Myeloma" (1 trials) and "Myelodysplastic Syndromes" (1 trials). Many other conditions were trialed in "HUG; Oncologie" in a lesser frequency.
Clinical Trials Intervention Types at HUG; Oncologie
Most popular intervention types in "HUG; Oncologie" are "Drug" (8 trials) and "Radiation" (1 trials). Other intervention types were less common.
The name of intervention was led by "Atezolizumab" (2 trials), "Bevacizumab" (2 trials), "Docetaxel" (2 trials), "Placebo" (2 trials) and "Atezolizumab (MPDL3280A) [TECENTRIQ], an engineered anti-PDL1 antibody" (1 trials). Other intervention names were less common.
Clinical Trials Genders at HUG; Oncologie
The vast majority of trials in "HUG; Oncologie" are
8 trials for "All" genders.
Clinical Trials Status at HUG; Oncologie
Currently, there are NaN active trials in "HUG; Oncologie".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 7 completed trials in HUG; Oncologie,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in HUG; Oncologie, 0 "Phase 1"
clinical trials were conducted, 3 "Phase 2" clinical
trials and 5 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".